Information about drugs is usually provided by manufacturers in the form of package inserts and labels, as well as promotional literature and advertisements. These shall be in keeping with the national health policy and in compliance with national regulations. They shall be reliable, accurate, informative, balanced, upto-date, capable of substantiation, not misleading and in good taste. In this regard government shall continue to:
i. Sustain ethical, professional and scientific standards regarding the content of package inserts, labels, advertisements and other drug promotional materials to ensure that health care providers, practitioners, and patients have accurate and relevant information about drugs;
ii. Prevent all forms of direct advertising of prescription and controlled drugs to consumers;
iii. Prevent media advertisements of drugs and drug products, whether orthodox or traditional medicines, used in the treatment of certain ailments and diseases, as contained in the drug laws of the country;
iv. Vet and approve advertisement scripts and formats in respect of the advertisement of OTC drugs; and
v. Undertake post-marketing surveillance of drugs in order to make appropriate changes in approved information in light of new relevant data.